Images
IRB hosts 13 researchers who have received the ICREA seal of recognition
Antonio Zorzano, coordinator of the Molecular Medicine Programme and head of the Heterogenic and polygenic diseases group, has been presented with the 2014 ICREA Academia Award 2014 by the Institució Catalana de Recerca i Estudis Avançats (ICREA).
Zorzano is a senior professor of Biochemistry and Molecular Biology at the University of Barcelona. He heads one of the most active research groups in Europe working on the molecular bases of insulin resistance and type 2 diabetes.
In the last ten years, Zorzano has published more than 100 original articles in the field of metabolism and associated diseases and has received more than 11,000 citations. He also founded Genmedica Therapeutics, a biotech enterprise focused on identifying drugs for the treatment of diabetes.
The ICREA Academia Awards are given for a period of five years and in recognition of the scientific trajectory of university lecturers. Awardees receive 40,000 per year over this period to support their lines of research. Since 2011, senior university lecturers that undertake their research in centres belonging to the Generalitat de Catalunya can be considered for this award. ICREA Academia professors decrease their dedication to teaching activities to concentrate on research.
Of the 23 group leaders currently at IRB, 11 are ICREA Researchers and 2 are ICREA Academia Professors. A foundation that belongs to the Generalitat de Catalunya, ICREA was set up to recruit, attract and retain scientific talent in CERCA centres and in universities in Catalonia. ICREA recognition is a seal of quality and excellence.
Related news:
9 April 2014
Identified a new possible target to combat muscle wasting
27 September 2013
Alterations in the interactions between organelles within neurons cause obesity
18 April 2012
ICREA Academia award 2011 for researcher Modesto Orozco
4 May 2011
Antonio Zorzano receives the Alberto Sols Senior Investigator Award for Basic Research
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
